The Drugs and Devices Australia Webinar 2024.

Hosted by our Partner & Director George Papadopoulos and Sarah Griffin Director of MedTechnique Consulting, covering a run-down of all the updates from 2024 in the complex world of drug and device reimbursement applications and strategy in the Australian market.

During this webinar George and Sarah  share valuable insights on navigating the complex landscape of drug and device reimbursement applications. Together, they will review the key trends from the past year, a comprehensive overview of the Australian Healthcare Landscape in 2024 and what to expect in 2025.

ISPOR 2024

Follow this link to watch our Director, George Papadopoulos who enjoyed attending ISPOR 2024, in Atlanta on May 5-8. Hear what George had to say about the conference in this video published by ISPOR after the event.

The ISPOR global conference is for health economics, it’s a  must-attend event providing attendees with dedicated opportunities to network with peers, HEOR experts, and thought leaders and to discuss with a global audience how we establish, incentivize, and share value sustainable for health systems, patients, and technology developers.

TRYP Therapeutics links up with Lucid Health Consulting.

Watch this video by Investor Stream, interviewing Tryp Chief Executive Officer, Mr. Jason Carroll, regarding the Appointment of Lucid Health Consulting to underpin product registration and reimbursement strategy to manage the registration and develop a comprehensive reimbursement strategy for their innovative treatment, TRP-8803, (IV-infused psilocin), in Australia. This appointment was announced to the press on 19 June 2024, read the ASX press release here – TYP-Press-Release

The Drugs and Devices Australia Webinar 2023.

Hosted by our Partner & Director George Papadopoulos and Sarah Griffin Director of MedTechnique Consulting, covering a run-down of all the updates from 2023 in the complex world of drug and device reimbursement applications and strategy in the Australian market. George and Sarah discuss the latest developments in gaining reimbursement in the Australian market, answer attendee questions and share their insights on what to expect in 2024.

The Drugs and Devices Australia Webinar 2022.

Hosted by our Partner & Director George Papadopoulos and Sarah Griffin Director of MedTechnique Consulting, sharing their insights into the complex world of drug and device reimbursement applications and strategy in the Australian market. George and Sarah discuss the latest developments in gaining reimbursement in the Australian market, wrap up the year 2022 and answer webinar attendee’s questions.

The Drugs and Devices Australia Webinar 2021.

Hosted by our Partner & Director George Papadopoulos and Sarah Griffin Director of MedTechnique Consulting, sharing their insights into the complex world of drug and device reimbursement applications and strategy in the Australian market. George and Sarah discuss the latest developments in gaining reimbursement in the Australian market, wrap up the year 2021 and answer webinar attendee’s questions.

Digital Health & Industry virtual panel discussion, hosted by the University of Sydney, 2021.

On Wednesday 21 July, 2021, our Director, George Papadopoulos participated as a panellist in the Digital Health & Industry virtual panel discussion, hosted by the University of Sydney, Digital Health ECR Community and co-ordinated by Audrey Rollin.

With the following panellists, Associate Professor Andrew Campbell of the University of Sydney, Dr David Hansen CEO of CSIRO’s Australian e-Health Research Centre, Ms Michelle Gallaher  CEO of Opyl, Natasa Lazaveric , PhD candidate in health science and physics at the University of Sydney and Arthur Brandwood, Director at ARCS Australia and George Papadopoulos, Director of Lucid Health Consulting.

The following key insights were shared during the live panel webinar discussion:

How to engage with industry and its critical role in digital health research translation;

How to bring research to market, where and when to look for funding opportunities, and how to connect with industry professionals;

The different pathways from academia to industry.

The Digital Health ECR used the Padlet discussion format to interact collaboratively live during the webinar and a copy of this discussion is available here: Digital Health ECR Industry Webinar Padlet PDF

6th Annual Drugs & Devices Australia – Reimbursement Update, 2020.

Hosted by our Partner & Director George Papadopoulos and  Sarah Griffin Director of MedTechnique Consulting, sharing their insights into the complex world of drug and device reimbursement applications and strategy in the Australian market. Sarah and George discuss the latest developments in gaining reimbursement in the Australian market.

The 5th Annual Drugs & Devices Australia Webinar – Reimbursement Update.

Learn the latest developments in gaining reimbursement in the Australian market and an overview of 2019 by viewing the Fifth Annual Drugs & Devices Australia, Webinar – Reimbursement Australia, 2019. Hosted by our Director George Papadopoulos and Sarah Griffin, Director of MedTechnique Consulting.

George and Sarah share their insights into the complex world of drug and device reimbursement applications and strategy in the Australian market: as well as answering webinar attendee’s questions.

Real world evidence: how is it being used in Australian pharmaceutical listings?

Watch an interview with Lucid Health Consulting’s Director and Chairman of ARCs Australia, George Papadopoulos and his guests, Professor Wilson, Director and Professor at Menzies Centre for Health Policy and Chair PBAC and Brittany Schoeninger, Associate Principle, IQVIA, as part of the ARCS Talks, during the ARCS Annual Conference, 2019.

The interview examines the evolving role of Real World Evidence in Australia – including how supply of and demand for RWE are changing locally – as well as explore how effective cross-functional evidence planning can help you translate Real World Data to Real World patient benefit.